Validity of commercial serologic tests for dermatomyositis still questionable

“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”

Address root causes to manage NASH

Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.

Promising drugs line up for lupus treatment

Lupus drugs in late-stage development seek to address unmet needs, notably in lupus nephritis.

Take drug, patient-level factors into account for when to end antiresorptive therapy

LAS VEGAS – The agent and individual patient factors may affect the duration of treatment and the approach to resuming therapy.

Fewer hypos with CGM in routine pediatric T1DM care

BERLIN – In the first year after the initiation of continuous glucose monitoring, hypoglycemia episodes needing external help were significantly reduced.

Children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes and cardiovascular disease

Risk for type 2 diabetes mellitus and cardiovascular disease in adulthood can be calculated by measuring cardiorespiratory fitness in childhood.

IgA vasculitis may be more common in adults than assumed

LAS VEGAS – Diagnosis and treatment of IgA vasculitis remain challenging, particularly in adults, and early monitoring is crucial.

Dermatology practice gaps: improving medication management

KAUAI, HAWAII – Ophthalmologists’ hydroxychloroquine dosing recommendations to avoid retinopathy have changed.

VIDEO: A challenging case of lichen planus

Think outside the box when treating difficult cases of lichen planus, lupus, and bullous pemphigoid.

Metabolic factors associated with pancreatic NETs

SAN DIEGO – Diabetes (not recent onset), obesity, and gallstone disease were associated with the occurrence of sporadic pancreatic neuroendocrine tumors (PNET) in the prospective, case-control European EpiNet study. Cigarette smoking, first-degree family history of...

Pages